Queen Mary University of London: Major Step Forward as Approach to Rare Disease Drug Development Yields First Research Results
July 09, 2026
July 09, 2026
LONDON, England, July 9 (TNSjou) -- Queen Mary University of London issued the following news:
* * *
Major step forward as new approach to rare disease drug development yields first research results.
The TREAT-EB collaboration between Queen Mary University of London and DEBRA Research aims to circumvent the discovery bottleneck blocking treatments for epidermolysis bullosa.
-
A team of scientists and business professionals at Queen . . .
* * *
Major step forward as new approach to rare disease drug development yields first research results.
The TREAT-EB collaboration between Queen Mary University of London and DEBRA Research aims to circumvent the discovery bottleneck blocking treatments for epidermolysis bullosa.
-
A team of scientists and business professionals at Queen . . .